Found: 120
Select item for more details and to access through your institution.
A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 3, p. 673, doi. 10.1007/s00432-021-03639-x
- By:
- Publication type:
- Article
Effects of CDC7 gene silencing and Rituximab on apoptosis in diffuse large B cell lymphoma cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 12, p. 2027, doi. 10.1007/s00432-012-1283-2
- By:
- Publication type:
- Article
Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 49, n. 3, p. 869, doi. 10.1159/000493218
- By:
- Publication type:
- Article
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 4, p. 1311, doi. 10.1159/000485491
- By:
- Publication type:
- Article
miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 4, p. 1670, doi. 10.1159/000479412
- By:
- Publication type:
- Article
MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 6, p. 1303, doi. 10.1159/000453183
- By:
- Publication type:
- Article
MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 3/4, p. 1303, doi. 10.1159/000453183
- By:
- Publication type:
- Article
Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 39, n. 5, p. 1716, doi. 10.1159/000447872
- By:
- Publication type:
- Article
A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid Tumor.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.833583
- By:
- Publication type:
- Article
Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34253-1
- By:
- Publication type:
- Article
Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 336, doi. 10.1093/jjco/hyv206
- By:
- Publication type:
- Article
Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2023, p. 1, doi. 10.1177/20406223231197311
- By:
- Publication type:
- Article
Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer.
- Published in:
- Journal of Physiology & Biochemistry, 2020, v. 76, n. 4, p. 549, doi. 10.1007/s13105-020-00759-9
- By:
- Publication type:
- Article
Anticancer drug R&D landscape in China.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition).
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0702-0
- By:
- Publication type:
- Article
Is hand grip strength a necessary supportive index in the phenotypic criteria of the GLIM-based diagnosis of malnutrition in patients with cancer?
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 7, p. 4001, doi. 10.1007/s00520-020-05975-z
- By:
- Publication type:
- Article
Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1166040
- By:
- Publication type:
- Article
Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1004345
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231186025
- By:
- Publication type:
- Article
miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer.
- Published in:
- Molecular Cancer, 2014, v. 13, p. 1, doi. 10.1186/1476-4598-13-220
- By:
- Publication type:
- Article
The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-92
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1–3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 6, p. 808, doi. 10.1007/s10637-023-01396-x
- By:
- Publication type:
- Article
Identification of HGF as a novel target of miR-15a/16/195 in gastric cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 922, doi. 10.1007/s10637-019-00834-z
- By:
- Publication type:
- Article
MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 5, p. 923, doi. 10.1007/s10637-018-0695-5
- By:
- Publication type:
- Article
Deregulation of the miR-16-KRAS axis promotes colorectal cancer.
- Published in:
- Scientific Reports, 2016, p. 37459, doi. 10.1038/srep37459
- By:
- Publication type:
- Article
Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145589
- By:
- Publication type:
- Article
miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130194
- By:
- Publication type:
- Article
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12072-5
- By:
- Publication type:
- Article
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03743-0
- By:
- Publication type:
- Article
lncRNA‐encoded pep‐AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
- Published in:
- EMBO Reports, 2022, v. 23, n. 1, p. 1, doi. 10.15252/embr.202153140
- By:
- Publication type:
- Article
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum].
- Published in:
- International Journal of Nanomedicine, 2022, v. 17, p. 1003, doi. 10.2147/IJN.S362734
- By:
- Publication type:
- Article
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer.
- Published in:
- International Journal of Nanomedicine, 2020, v. 15, p. 2323, doi. 10.2147/IJN.S231214
- By:
- Publication type:
- Article
Role of HPV16/18/45 DNA Testing of Cervical Specimens as A Triage Testing in Cervical Cancer Screening.
- Published in:
- Acta Academiae Medicinae Sinica, 2013, v. 35, n. 3, p. 254, doi. 10.3881/j.issn.1000-503X.2013.03.003
- By:
- Publication type:
- Article
Effect of Sleep Deprivation on the Working Memory-Related N2-P3 Components of the Event-Related Potential Waveform.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. 1, doi. 10.3389/fnins.2020.00469
- By:
- Publication type:
- Article
Classification Tree–Based Machine Learning to Visualize and Validate a Decision Tool for Identifying Malnutrition in Cancer Patients.
- Published in:
- JPEN Journal of Parenteral & Enteral Nutrition, 2021, v. 45, n. 8, p. 1736, doi. 10.1002/jpen.2070
- By:
- Publication type:
- Article
iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 12, p. 3430, doi. 10.1002/1878-0261.13052
- By:
- Publication type:
- Article
Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 3, p. 539, doi. 10.1002/1878-0261.12629
- By:
- Publication type:
- Article
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02841-7
- By:
- Publication type:
- Article
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10863-w
- By:
- Publication type:
- Article
Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10661-4
- By:
- Publication type:
- Article
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01168-8
- By:
- Publication type:
- Article
Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
- Published in:
- Advanced Science, 2022, v. 9, n. 28, p. 1, doi. 10.1002/advs.202203357
- By:
- Publication type:
- Article
Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index‐based clinical algorithm—A multicentre study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6207, doi. 10.1002/cam4.4155
- By:
- Publication type:
- Article
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1681, doi. 10.1002/cam4.3771
- By:
- Publication type:
- Article
Nutritional status and survival of 8247 cancer patients with or without diabetes mellitus—results from a prospective cohort study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7428, doi. 10.1002/cam4.3397
- By:
- Publication type:
- Article
First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 4, p. 749, doi. 10.1002/ijc.34296
- By:
- Publication type:
- Article
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA.
- Published in:
- Cell Research, 2012, v. 22, n. 1, p. 107, doi. 10.1038/cr.2011.158
- By:
- Publication type:
- Article
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice